12:00 AM
 | 
Oct 27, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Endeavor cardiovascular data

The Danish SORT OUT III trial showed that the 9-month target lesion revascularization (TLR) rate was 4% with Endeavor vs. 1% with

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >